Detalles de la búsqueda
1.
Epidemiological features and prognosis for primary gastrointestinal follicular lymphoma.
Br J Haematol
; 204(5): 1771-1779, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38447995
2.
Metabolic pathway-based subtyping reveals distinct microenvironmental states associated with diffuse large B-cell lymphoma outcomes.
Hematol Oncol
; 42(4): e3279, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38819002
3.
OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphoma.
Clin Immunol
; 251: 109637, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37150239
4.
Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma.
Br J Haematol
; 202(6): 1151-1164, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37455019
5.
Improved method to stratify lymphoma patients with risk of secondary central nervous system involvement: A multicenter retrospective analysis.
Hematol Oncol
; 41(2): 239-247, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34564882
6.
A retrospective analysis of EBV-DNA status with the prognosis of lymphoma.
J Cell Mol Med
; 26(20): 5195-5201, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36065965
7.
A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma.
Clin Immunol
; 243: 109105, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36055572
8.
Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA.
Br J Haematol
; 196(3): 617-628, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34664256
9.
A novel clinical immune-related prognostic model predicts the overall survival of mantle cell lymphoma.
Hematol Oncol
; 40(3): 343-355, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35368100
10.
Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta-analysis.
Ann Hematol
; 101(11): 2383-2392, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36029326
11.
Ibrutinib improves the efficacy of anti-CD19-CAR T-cell therapy in patients with refractory non-Hodgkin lymphoma.
Cancer Sci
; 112(7): 2642-2651, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33932067
12.
Reduced radiotherapy clinical benefit for primary Waldeyer's ring diffuse large B-cell lymphoma in the rituximab era.
Hematol Oncol
; 39(4): 490-497, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33908077
13.
Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer.
J Nanobiotechnology
; 19(1): 181, 2021 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34120612
14.
Combination of baseline total metabolic tumor volume measured on FDG-PET/CT and ß2-microglobulin have a robust predictive value in patients with primary breast lymphoma.
Hematol Oncol
; 38(4): 493-500, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32533716
15.
Tumor CD73/A2aR adenosine immunosuppressive axis and tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma: correlations with clinicopathological characteristics and clinical outcome.
Int J Cancer
; 145(5): 1414-1422, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30664812
16.
CD5 expression correlates with inferior survival and enhances the negative effect of p53 overexpression in diffuse large B-cell lymphoma.
Hematol Oncol
; 37(4): 360-367, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31359442
17.
Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T-cell lymphomas.
Hematol Oncol
; 37(3): 270-276, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31074879
18.
Correction to: Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and metaanalysis.
Ann Hematol
; 101(12): 2817, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36255465
19.
Comprehensive analysis of TP53 mutation characteristics and identification of patients with inferior prognosis and enhanced immune escape in diffuse large B-cell lymphoma.
Am J Hematol
; 97(1): E14-E17, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34710245
20.
Accelerated therapeutic progress in diffuse large B cell lymphoma.
Ann Hematol
; 93(4): 541-56, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24375125